Category: MassDevice Q&A
Med-tech industry leaders came together for a meeting of the minds at MassDevice's first Big 100 Regional Roundtable in Waltham, Mass., last night.
FDA CDRH chief Dr. Jeffrey Shuren addresses the
audience in a live Q&A
Hundreds of representatives from New England's medical device industry gathered last night at the MassDevice Big 100 Regional Roundtable at the Westin Hotel in Waltham, Mass., to share their experiences and ideas for the industry's future.
Eamonn Hobbs, president & CEO of Delcath Systems, on his company's volatile stock, surprising FDA decisions and how to keep chemotherapy where it belongs.
Delcath Systems Inc. (NSDQ:DCTH) CEO Eamonn Hobbs is in a good mood these days.
MassDevice.com names 28 chief executives in the medical device industry, who exemplify cutting-edge leadership and innovative thinking, for its inaugural CEO Class of 2011.
MassDevice.com, the online business journal for the medical device industry, is proud to name 28 chief executives whom we feel represent cutting-edge leadership and innovative thinking for our inaugural CEO Class of 2011.
A radio signal transmitter developed by researchers at MIT and UMass Amherst is the first to provide a non-invasive solution to hacking vulnerabilities in implanted medical devices.
Wireless devices have changed the way health information moves, making data more abundant and more accessible. But it's also made medical devices more vulnerable.
Researchers at MIT and the University of Mass. Amherst are the first to develop a technology that could protect the millions of existing medical device implants without altering or replacing them.
Wireless technologies made their mark on medical devices in a big way, attaching themselves to everything from pacemakers and defibrillators to insulin pumps and nerve stimulators.
Draper Labs has watched micro-electro-mechanical technologies go from a head-scratcher to a no-brainer in the last 10 years, with possible commercial partnerships right around the corner.
A bio-MEM drug delivery device developed by Draper Labs
Draper was into bio-MEMs before they were cool.
Micro-electro-mechanical systems, also known as MEMs, are tiny electrical machines that are common in consumer electronics and automotive sensors. Their presence in medical technology, however, is a much newer phenomenon.
In the last 10 years, as bio-MEMs technology has gone from being a head-scratcher to being a no-brainer, Jeffrey Borenstein has had a front-row seat.
Echo Therapeutics CEO Dr. Patrick Mooney on the story of his company, which is developing a transdermal continuous glucose monitoring device for the diabetes market.
Dr. Patrick Mooney took an interesting path to the top seat at Echo Therapeutics Inc. (OTC:ECTE), a Philadelphia, Pa.-based company developing a non-invasive, wireless, transdermal continuous glucose monitoring device for the diabetes market.
Medtronic CFO Gary Ellis speaks to MassDevice about the company's just-released earnings, why the cardiac rhythm management market is depressed and whether there's been any fallout from canceling a GPO deal with Novation.
The waters around the good ship Medtronic Inc. (NYSE:MDT) have been a bit frothy these days.